Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipelinenews2026-04-17T16:06:25+00:00April 17th, 2026|Endpoints News|
Kailera raises $625M IPO in biotech recordnews2026-04-17T11:28:56+00:00April 17th, 2026|Endpoints News|
Updated: Seaport and Hemab file for IPOs, as Kailera pricesnews2026-04-13T01:10:39+00:00April 13th, 2026|Endpoints News|
Pulmonary fibrosis biotech Avalyn Pharma files for IPOnews2026-04-09T01:20:45+00:00April 9th, 2026|Endpoints News|
